Can polygenic risk scores reliably predict autism?
Polygenic risk scores (PRS) are a promising tool in the field of autism prediction, but their reliability is still evolving. These scores combine the effects of many small genetic variations, known as genetic markers, to estimate an individual’s likelihood of developing a certain condition. In autism, this approach reflects the complex, multifactorial nature of the condition, which involves hundreds of genes, each contributing a small amount to overall risk.
Current research shows that while polygenic risk scores can distinguish, on average, between people with and without autism, they are not yet precise enough for individual diagnosis. The variability in how autism presents, combined with environmental influences and gene–environment interactions, means that risk scores are only one piece of the puzzle. However, as more genetic data becomes available, the accuracy of PRS is likely to improve, making them a potential tool for early risk assessment in the future.
How Polygenic Risk Scores Support Autism Research
Here are two ways polygenic risk scores are contributing to our understanding of autism:
Highlight genetic patterns across large populations
By analysing data from thousands of individuals, researchers can identify genetic signatures that are more common in people with autism. These insights help refine genetic models and guide future studies.
Inform broader risk screening tools
Although not yet suitable for clinical use on their own, PRS may eventually be combined with behavioural or neurological assessments to create more comprehensive autism screening frameworks.
The development of polygenic risk scores brings us closer to more personalised, predictive approaches to autism prediction. Visit providers like Autism Detect for personal consultations and further guidance on screening and support.
For a deeper dive into the science, diagnosis and full treatment landscape, read our complete guide to Genetic Influences.

